Abstract
Aim and Objective: We synthesized eicosapentaenoic acid-enriched phosphatidylcholine (EPA-PC) and investigated its effect on the production of lipopolysaccharide (LPS)- induced cytokines in murine splenocytes.
Material and Methods: The culture supernatants of splenocytes, which was exposed to EPA-PC along with LPS, was harvested to determine the production of cytokines [interleukin (IL)-4 , IL-5, IL-6, interferon (IFN)-γ, IL-2 and IL-12/IL-23(p40)]. Cytokines were measured using enzymelinked immunosorbent assay (ELISA).
Results: The co-administration of EPA-PC with LPS resulted in a significantly lower IFN-γ expression than that observed with LPS alone (p < 0.01). Moreover, treatment with EPA-PC and LPS significantly decreased IL-2, IL-6 and IL-12/IL-23(p40) expression (p < 0.01). Coadministration of EPA-PC at a concentration of 0.3 μg/mL with LPS resulted in a higher IL-5 expression after 24 hr of treatment when compared to LPS alone (p < 0.05).
Conclusion: These results suggest that EPA-PC is more effective in decreasing the expression of pro-inflammatory cytokines [IL-2, IFN-γ, IL-6 and IL-12/IL-23(p40)] upon induction of inflammation.
Keywords: Eicosapentaenoic acid, phosphatidylcholine, cytokines, PUFAs, EPA, LPS.
Graphical Abstract
[http://dx.doi.org/10.1016/j.plefa.2010.06.007] [PMID: 20638827]
[http://dx.doi.org/10.1021/bi00295a045]
[http://dx.doi.org/10.1016/0005-2760(92)90262-T] [PMID: 1390881]
[http://dx.doi.org/10.1016/S1096-4959(02)00263-4] [PMID: 12568811]
[http://dx.doi.org/10.1017/S0029665113001031] [PMID: 23668691]
[http://dx.doi.org/10.1016/j.ejphar.2007.10.049] [PMID: 18021769]
[http://dx.doi.org/10.1016/j.nut.2011.08.001] [PMID: 21907900]
[http://dx.doi.org/10.1097/SHK.0b013e31822f36b0] [PMID: 21937953]
[http://dx.doi.org/10.1097/SHK.0b013e318173e8d4] [PMID: 18496240]
[http://dx.doi.org/10.32604/biocell.2020.08648]
[http://dx.doi.org/10.5352/JLS.2013.23.9.1140]
[http://dx.doi.org/10.1016/S0040-4020(01)01057-2]
[http://dx.doi.org/10.1016/j.cccn.2004.01.011] [PMID: 15115689]
[http://dx.doi.org/10.1615/JEnvironPatholToxicolOncol.v31.i2.10] [PMID: 23216634]
[http://dx.doi.org/10.1378/chest.117.4.1162] [PMID: 10767254]
[http://dx.doi.org/10.1093/jn/127.1.37] [PMID: 9040541]
[http://dx.doi.org/10.1186/1476-511X-11-3] [PMID: 22221489]
[http://dx.doi.org/10.4196/kjpp.2013.17.3.209] [PMID: 23776397]
[PMID: 12903861]
[http://dx.doi.org/10.1371/journal.pone.0132741] [PMID: 26177196]
[PMID: 9547608]
[http://dx.doi.org/10.1006/jsre.1998.5524] [PMID: 10090832]
[PMID: 3041642]
[http://dx.doi.org/10.1111/j.1523-1755.2005.00151.x] [PMID: 15698426]
[http://dx.doi.org/10.1590/S0100-879X2009005000003] [PMID: 19466285]
[http://dx.doi.org/10.1016/j.plipres.2010.01.002] [PMID: 20176053]
[http://dx.doi.org/10.1016/j.mam.2011.10.002] [PMID: 22020145]